TYLOSIN/ANAFASIS 100% ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ
TYLOSIN/ANAFASIS 100% ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ
Authorised
- Tylosin tartrate
Product identification
Medicine name:
TYLOSIN/ANAFASIS 100% ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
- Tylosin tartrate
Target species:
-
Chicken
-
Turkey
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Tylosin tartrate1000.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Powder for oral solution
Withdrawal period by route of administration:
-
Oral use
-
Chicken
-
Meat and offal1day
-
Egg0day
-
-
Turkey
-
Meat and offal5day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Anafasis Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Uplab Pharmaceutical Company Ltd.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 27478/23-04-2008/K-0083802
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet